Share Price Performance Share price performance can be measured using the movement in the Argo share price (ASX code: ARG) assuming that dividends paid are reinvested. The figures below are compound annual growth rates and are compared with the S&P/ASX 200 Accumulation Index for various periods.
Brachytherapy may cause temporary urinary problems from swelling of the prostate after the insertion of the hollow needles when the seed implant is performed. Brachytherapy may also cause temporary bowel problems.
An enlarged prostate can lead to symptoms of increased urinary frequency from the loss of the ability to get the bladder totally empty. It may also lead to a weak urine stream or difficulty in initiating urination. In very rare cases, an enlarged prostate can lead to the inability to urinate due to total or near total obstruction of the urethra. This may lead to urine infections or cause urine to back up into the kidneys.